Oxybutynin Chloride
Brand name: Oxybutynin Chloride Er
Rank #242 of 500 drugs by total cost
$53.4M
Total Cost
1,872,901
Total Claims
$53.4M
Total Cost
62,249
Prescribers
$29
Cost per Claim
278,509
Beneficiaries
3,476,553
30-Day Fills
$858
Avg Cost/Provider
30
Avg Claims/Provider
About Oxybutynin Chloride
Oxybutynin Chloride (sold as Oxybutynin Chloride Er) was prescribed 1,872,901 times by 62,249 Medicare Part D providers in 2023, costing the program $53.4M. At $29 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 239 | Amifampridine Phosphate (Firdapse) | $54.4M | 1,203 |
| 240 | Dapaglifloz Propaned/Metformin (Xigduo Xr) | $54.4M | 58,629 |
| 241 | Buspirone Hcl (Buspirone Hcl) | $53.7M | 2,868,147 |
| 242 | Oxybutynin Chloride (Oxybutynin Chloride Er) | $53.4M | 1,872,901 |
| 243 | Raltegravir Potassium (Isentress) | $53.0M | 25,491 |
| 244 | Belumosudil Mesylate (Rezurock) | $52.3M | 2,280 |
| 245 | Pegloticase (Krystexxa) | $52.2M | 1,134 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology